UK health leaders urge chancellor to invest in a smoke-free UK
Over 200 leading doctors, professional bodies and charities are urging the chancellor to use the budget on 30 October to invest in creating a smoke free UK as […]
ADVERTISMENT
Over 200 leading doctors, professional bodies and charities are urging the chancellor to use the budget on 30 October to invest in creating a smoke free UK as […]
Tobacco use remains a significant global health challenge, despite extensive control measures at both national and international levels. Smoking continues to be a leading cause of premature death, […]
Analyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect […]
A new study from the Texas A&M University School of Public Health found that only 9 percent of older Americans had been vaccinated against respiratory syncytial virus (RSV) prior to this fall and winter, […]
Coughing after a respiratory infection is common and, in most cases, will resolve with time, according to an article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231523. With the recent bout of […]
A new analysis of trial data on pregnant smokers, led by researchers at Queen Mary University of London, finds that the regular use of nicotine replacement products during […]
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease’s significant burden of illness and death in the United States if […]
Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, […]
A new study from the Texas A&M University School of Public Health suggests that vaping increases the risk of asthma in adolescents who have never smoked conventional tobacco products. Vaping, […]
EU medicines regulators have approved a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation […]
Researchers supported by the National Institutes of Health have found that dual bronchodilators — long-lasting inhalers that relax the airways and make it easier to breathe — do […]
Researchers report that two years after diagnosis half of patients hospitalized with COVID-19 have at least one ongoing symptom. The findings appeared in on May 11, 2022 in […]